Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Open-market sale. Sales can have many reasons; shown without inference.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Oct 24, 2024
Reporting period
Not applicable
Filed with the SEC
Oct 25, 2024
10% owner
Context
Classification
open market sale
Code S — open-market or private sale
Timing vs results
84 days after results of Aug 1, 2024, 7 days before results of Oct 31, 2024
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Planned / mechanical clue
None found in footnotes
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001816590-24-000126
Filed / recorded
Oct 25, 2024, 12:27 PM UTC
Added to OQRO
Oct 9, 2026, 6:13 PM UTC
Parser
form4-xml-v2
Data quality
Needs review
Issuer
COMPASS Pathways plc
Issuer CIK
1816590
Ticker
CMPS
Reporting person
Malievskaia Ekaterina
Relationship
10% owner
Security
Ordinary Shares
Table
Non-derivative (Table I)
Transaction date
Oct 24, 2024
Transaction code
S
Shares / units
776,565
Acquired / disposed
Disposed (D)
Shares owned after
3,152,848
Ownership form
Direct
Amendment
No
Footnotes from the filing
The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share.
The transaction is a private sale of American Depositary Shares (ADSs) to Lars Wilde, a former co-founder of Compass Pathways plc (the "Company"), pursuant to the terms of previously disclosed call option agreements dated May 19, 2020, as amended and restated on July 21, 2020, as further amended and restated on September 9, 2020, and as further amended effective February 15, 2023 by and among the Company and Mr. Wilde and each of Mr. Goldsmith and Dr. Malievskaia. Pursuant to the terms of such agreements, Mr. Wilde had an option to purchase 776,565 of ADSs for the nominal value per ordinary share, from each of Mr. Goldsmith and Dr. Malievskaia, exercisable at any time following our initial public offering until September 9, 2033. On October 24, 2024, Mr. Wilde delivered irrevocable exercise notices to purchase 776,565 from each of Mr. Goldsmith and Dr. Malievskaia.
4 tracked managers disclosed the same change for Q3 2024. From a 13F filed Nov 14, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
4 tracked managers disclosed the same change for Q3 2024. From a 13F filed Oct 31, 2024 covering holdings at Sep 30, 2024 — a quarter-end snapshot, not a live trade.
